Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?

Surgery

Volumn 145, Issue 1, 2009, Pages 9-19

  Inoue, Yosuke ^a   Hasegawa, Kiyoshi ^a   Ishizawa, Takeaki ^a   Aoki, Taku ^a   Sano, Keiji ^b   Beck, Yoshifumi ^a   Imamura, Hiroshi ^a   Sugawara, Yasuhiko ^a   Kokudo, Norihiro ^a   Makuuchi, Masatoshi ^b  

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISSECTION; FEMALE; HEMIHEPATECTOMY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT CODING; PHLEBOTOMY; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PORTAL VENOUS TUMOR THROMBUS; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURGICAL THROMBECTOMY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VEIN WALL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISSECTION; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBECTOMY; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 57149097447     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.09.005     Document Type: Article

References (41)

1. Llovet J.M., Bustamante J., Castells A., Vilana R., Ayuso Mdel C., Sala M., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29 (1999) 62-67
2. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan. Cancer 74 (1994) 2772-2780
3. Vauthey J.N., Klimstra D., Franceschi D., Tao Y., Fortner J., Blumgart L., et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169 (1995) 28-34
4. Chung J.W., Park J.H., Han J.K., Choi B.I., and Han M.C. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 165 (1995) 315-321
5. Lee H.S., Kim J.S., Choi I.J., Chung J.W., Park J.H., and Kim C.Y. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79 (1997) 2087-2094
6. Hata M., Tokuuye K., Sugahara S., Kagei K., Igaki H., Hashimoto T., et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104 (2005) 794-801
7. Tazawa J., Maeda M., Sakai Y., Yamane M., Ohbayashi H., Kakinuma S., et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 16 (2001) 660-665
8. Itamoto T., Nakahara H., Tashiro H., Haruta N., Asahara T., Naito A., et al. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. J Surg Oncol 80 (2002) 143-148
9. Ando E., Tanaka M., Yamashita F., Kuromatsu R., Yutani S., Fukumori K., et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 95 (2002) 588-595
10. Okada S., Okazaki N., Nose H., Yoshimori M., and Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 16 (1992) 112-117
11. Ando E., Yamashita F., Tanaka M., and Tanikawa K. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79 (1997) 1890-1896
12. Obi S., Yoshida H., Toune R., Unuma T., Kanda M., Sato S., et al. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106 (2006) 1990-1997
13. Livraghi T., Grigioni W., Mazziotti A., Sangalli G., and Vettori C. Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment. Tumori 76 (1990) 394-397
14. Ohkubo T., Yamamoto J., Sugawara Y., Shimada K., Yamasaki S., Makuuchi M., et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191 (2000) 657-660
15. Gotohda N., Kinoshita T., Konishi M., Nakagohri T., Takahashi S., Furuse J., et al. New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement. World J Surg 30 (2006) 431-438
16. Minagawa M., Makuuchi M., Takayama T., and Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 233 (2001) 379-384
17. Wu C.C., Hsieh S.R., Chen J.T., Ho W.L., Lin M.C., Yeh D.C., et al. An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 135 (2000) 1273-1279
18. Yamaoka Y., Kumada K., Ino K., Takayasu T., Shimahara Y., Mori K., et al. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein. World J Surg 16 (1992) 1172-1176
19. Tanaka A., Morimoto T., and Yamaoka Y. Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology 43 (1996) 637-643
20. Makuuchi M., Hasegawa H., and Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161 (1985) 346-350
21. Imamura H., Matsuyama Y., Miyagawa Y., Ishida K., Shimada R., Miyagawa S., et al. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 86 (1999) 1032-1038
22. Hasegawa K., Kokudo N., Imamura H., Matsuyama Y., Aoki T., Minagawa M., et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242 (2005) 252-259
23. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
24. Marsh J.W., Dvorchik I., Subotin M., Balan V., Rakela J., Popechitelev E.P., et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26 (1997) 444-450
25. Hemming A.W., Cattral M.S., Reed A.I., Van Der Werf W.J., Greig P.D., and Howard R.J. Liver transplantation for hepatocellular carcinoma. Ann Surg 233 (2001) 652-659
26. Makuuchi M., Kosuge T., Takayama T., Yamazaki S., Kakazu T., Miyagawa S., et al. Surgery for small liver cancers. Semin Surg Oncol 9 (1993) 298-304
27. Kubota K., Makuuchi M., Kusaka K., Kobayashi T., Miki K., Hasegawa K., et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26 (1997) 1176-1181
28. Couinaud C. Lobes et segments hepatiques. [in French]. Presse Med 62 (1954) 709-712
29. Torzilli G., Donadon M., Palmisano A., Del Fabbro D., Spinelli A., Makuuchi M., et al. Back-flow bleeding control during resection of right-sided liver tumors by means of ultrasound-guided finger compression of the right hepatic vein at its caval confluence. Hepatogastroenterology 54 (2007) 1364-1367
30. Minagawa M., Makuuchi M., Takayama T., and Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238 (2003) 703-710
31. Kumada K., Ozawa K., Okamoto R., Takayasu T., Yamaguchi M., Yamamoto Y., et al. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery 108 (1990) 821-827
32. Bruix J., and Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35 (2002) 519-524
33. Jaeck D., Bachellier P., Oussoultzoglou E., Weber J.C., and Wolf P. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview. Liver Transpl 10 2 Suppl 1 (2004) S58-S63
34. Ikai I., Yamamoto Y., Yamamoto N., Terajima H., Hatano E., Shimahara Y., et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin North Am 12 (2003) 65-75
35. Asahara T., Itamoto T., Katayama K., Nakahara H., Hino H., Yano M., et al. Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures. Hepatogastroenterology 46 (1999) 1862-1869
36. Konishi M., Ryu M., Kinoshita T., and Inoue K. Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 48 (2001) 1421-1424
37. Fukuda S., Okuda K., Imamura M., Imamura I., Eriguchi N., and Aoyagi S. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 131 (2002) 300-310
38. Pawlik T.M., Poon R.T., Abdalla E.K., Ikai I., Nagorney D.M., Belghiti J., et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137 (2005) 403-410
39. Ikai I., Hatano E., Hasegawa S., Fujii H., Taura K., Uyama N., et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202 (2006) 431-438
40. Tsai T.J., Chau G.Y., Lui W.Y., Tsay S.H., King K.L., Loong C.C., et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127 (2000) 603-608
41. Makuuchi M., Thai B.L., Takayasu K., Takayama T., Kosuge T., Gunven P., et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107 (1990) 521-527